Recently, ProteinX, an AI-driven full-stack protein research and development platform, announced the completion of its Series A+ financing round, securing over 200 million yuan. This round of financing was jointly led by PetroChina Kunlun Capital, existing shareholder Yonghua Investment, and Shanghai Future Industry Fund, with participation from other investors including China Investment & Merchants Capital, New Supply and Marketing Fund, Farmakey, and Futeng Capital. Additionally, existing shareholders Qiming Venture Partners, GSR United Capital Runpu Healthcare Fund, and 3E Bioventures continued to increase their investments.
